Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription 25.10.2021 1 Am Heart J 4 Am J Cardiol 1 Am J Crit Care 1 Am J Med 1 BMJ 86 Catheter Cardiovasc Interv 1 Chest 1 Circ Cardiovasc Imaging 4 Circ Cardiovasc Interv 1 Circ Genom Precis Med 3 Circulation 9 Clin Cardiol 1 Dtsch Med Wochenschr 3 Eur Heart J 2 Heart 25 Int J Cardiol 1 J Am Coll Cardiol 2 J Cardiovasc Pharmacol 1 J Mol Cell Cardiol 3 J Thorac Cardiovasc Surg 1 N Engl J Med 6 PLoS One 2 Psychosom Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. AMINIAN A, Sgueglia GA, Wiemer M, Gasparini GL, et al
   Distal versus conventional radial access for coronary angiography and intervention: design and rationale of DISCO RADIAL Study.
   Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00432.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. SHAH A, Bazemore T, Wolf H, Yang H, et al
   Length of Preprocedure Fasting Was Associated With Contrast Associated-Acute Kidney Injury in High-Risk Patients Undergoing Coronary Angiography.
   Am J Cardiol. 2021;159:1-7.
   PubMed         Abstract available
   
   
3. ZHU Z, Bundy JD, Mills KT, Bazzano LA, et al
   Secular Trends in Cardiovascular Health in US Adults (from NHANES 2007 to 2018).
   Am J Cardiol. 2021;159:121-128.
   PubMed         Abstract available
   
   
4. AVIV Y, Shechter A, Richter I, Kornowski R, et al
   Temporal Trends in the Characteristics, Treatment, and Outcomes of Conservatively Managed Patients With Non-ST Elevation Acute Coronary Syndrome (from the ACSIS Registry 2000 to 2016).
   Am J Cardiol. 2021;159:52-58.
   PubMed         Abstract available
   
   
5. KOBO O, Moledina SM, Slawnych M, Sinnarajah A, et al
   Predictors, Treatments, and Outcomes of Do-Not-Resuscitate Status in Acute Myocardial Infarction Patients (from a Nationwide Inpatient Cohort Study).
   Am J Cardiol. 2021;159:8-18.
   PubMed         Abstract available
   
   

   
   Am J Crit Care

6. AL-ZAITI SS, Kozik TM, Pelter MM, Carey MG, et al
   Refractory Angina Confounded by Preexcitation Syndrome.
   Am J Crit Care. 2021;30:407-408.
   PubMed        
   
   

   
   Am J Med

7. RIAZ H
   Desperate Times, Desperate Measures: Same Day Discharge for ST Segment Elevation Myocardial Infarction Patients.
   Am J Med. 2021 Oct 14. pii: S0002-9343(21)00650.
   PubMed        
   
   

   
   BMJ

8. MAHASE E
   US taskforce advises against low dose aspirin for primary prevention of cardiovascular disease.
   BMJ. 2021;375:n2521.
   PubMed        
   
   

   
   Catheter Cardiovasc Interv

9. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
   Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
   Catheter Cardiovasc Interv. 2021;98:E197-E204.
   PubMed         Abstract available
   
   
10. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    PubMed         Abstract available
    
    
11. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    PubMed         Abstract available
    
    
12. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    PubMed         Abstract available
    
    
13. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    PubMed         Abstract available
    
    
14. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    PubMed         Abstract available
    
    
15. TU S, Ding D, Chang Y, Li C, et al
    Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: A novel method based on bifurcation fractal law.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29592.
    PubMed         Abstract available
    
    
16. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    PubMed         Abstract available
    
    
17. REN Y, Li X, Wang S, Pan W, et al
    Serum alkaline phosphatase levels are associated with coronary artery calcification patterns and plaque vulnerability.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1055-1062.
    PubMed         Abstract available
    
    
18. ZHAO Y, Li J, Ma S, Jiang Z, et al
    Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2021;98:E235-E242.
    PubMed         Abstract available
    
    
19. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    PubMed         Abstract available
    
    
20. LI C, Yang J, Dong S, Dong L, et al
    Multicenter clinical evaluation of a piezoresistive-MEMS-sensor rapid-exchange pressure microcatheter system for fractional flow reserve measurement.
    Catheter Cardiovasc Interv. 2021;98:E243-E253.
    PubMed         Abstract available
    
    
21. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    PubMed         Abstract available
    
    
22. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    PubMed         Abstract available
    
    
23. PAGNONI M, Meier D, Candreva A, Maillard L, et al
    Future culprit detection based on angiography-derived FFR.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29736.
    PubMed         Abstract available
    
    
24. XU M, Demuyakor A, Hu S, Liu H, et al
    Is the effect of atorvastatin 60 mg on stabilization of lipid-rich plaque equivalent to that of rosuvastatin 10 mg? A serial optical coherence tomography combined with intravascular ultrasound imaging.
    Catheter Cardiovasc Interv. 2021 Apr 17. doi: 10.1002/ccd.29654.
    PubMed         Abstract available
    
    
25. TZANIS G, Khokhar AA, Ponticelli F, Gallone G, et al
    Coronary sinus size and ischemia improvement after reducer implantation; "one size to fit them all?"
    Catheter Cardiovasc Interv. 2021;98:E365-E369.
    PubMed         Abstract available
    
    
26. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    PubMed         Abstract available
    
    
27. CORDERO A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, et al
    Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
    Catheter Cardiovasc Interv. 2021;98:E342-E350.
    PubMed         Abstract available
    
    
28. PADKINS M, Breen T, Van Diepen S, Barsness G, et al
    Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity.
    Catheter Cardiovasc Interv. 2021;98:330-340.
    PubMed         Abstract available
    
    
29. LI X, Qiu M, Na K, Li Y, et al
    Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1032-1039.
    PubMed         Abstract available
    
    
30. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    PubMed         Abstract available
    
    
31. TAO L, Li Z, Yin Z, Lin W, et al
    Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Feb 19. doi: 10.1002/ccd.29553.
    PubMed         Abstract available
    
    
32. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    PubMed         Abstract available
    
    
33. LHERMUSIER T, Carrie D, Cayla G, Fajadet J, et al
    Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:511-519.
    PubMed         Abstract available
    
    
34. YAGER N, Schulman-Marcus J, Torosoff M
    Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:436-444.
    PubMed         Abstract available
    
    
35. JONES TL, Golomb M, Dranow E, Welt FGP, et al
    The case for a qualitative lesion assessment system for coronary angiography.
    Catheter Cardiovasc Interv. 2020 Oct 31. doi: 10.1002/ccd.29334.
    PubMed         Abstract available
    
    
36. KERKMEIJER LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, et al
    Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
    Catheter Cardiovasc Interv. 2021;98:713-720.
    PubMed         Abstract available
    
    
37. SAPONTIS J, Hirai T, Patterson C, Gans B, et al
    Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) stud
    Catheter Cardiovasc Interv. 2021;98:626-635.
    PubMed         Abstract available
    
    
38. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    PubMed         Abstract available
    
    
39. KINI AS, Okamoto N, Barman N, Vengrenyuk Y, et al
    Side branch fractional flow reserve after provisional stenting of calcified bifurcation lesions: The ORBID-FFR study.
    Catheter Cardiovasc Interv. 2021;98:658-668.
    PubMed         Abstract available
    
    
40. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    PubMed         Abstract available
    
    
41. WATANABE Y, Mitomo S, Naganuma T, Takagi K, et al
    Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry.
    Catheter Cardiovasc Interv. 2021;98:E24-E34.
    PubMed         Abstract available
    
    
42. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    PubMed         Abstract available
    
    
43. WU EB
    Rebuttal: Misconceptions in crossboss/stingray catheter use-Clarification from the hybrid group.
    Catheter Cardiovasc Interv. 2021;98:616.
    PubMed        
    
    
44. ALEJANDRO GB, Gheorghe LL, Camacho Freire S, Silva E, et al
    Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29557.
    PubMed         Abstract available
    
    
45. PERSHAD A, Grantham JA, Thompson CA, Lombardi WL, et al
    Misconception in CrossBoss/stingray catheter use-clarification from the hybrid group.
    Catheter Cardiovasc Interv. 2021;98:615.
    PubMed        
    
    
46. AZZALINI L, Carlino M
    A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry.
    Catheter Cardiovasc Interv. 2021;98:E85-E90.
    PubMed         Abstract available
    
    
47. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    PubMed         Abstract available
    
    
48. MASDJEDI K, van Zandvoort LJ, Balbi MM, Nuis RJ, et al
    Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting.
    Catheter Cardiovasc Interv. 2020 Oct 6. doi: 10.1002/ccd.29311.
    PubMed         Abstract available
    
    
49. DAHAL S, Budoff MJ
    Anatomic burden mostly outperforms ischemic burden: From COURAGE to ISCHEMIA.
    Catheter Cardiovasc Interv. 2021;98:E106-E107.
    PubMed        
    
    
50. MEMON S, George JC, Kalra S, Janzer S, et al
    Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent.
    Catheter Cardiovasc Interv. 2021;98:743-747.
    PubMed         Abstract available
    
    
51. KERKMEIJER LSM, Chandrasekhar J, Kalkman DN, Woudstra P, et al
    Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Catheter Cardiovasc Interv. 2021;98:503-510.
    PubMed         Abstract available
    
    
52. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    PubMed         Abstract available
    
    
53. DUNN AN, Huded C, Simpfendorfer C, Raymond R, et al
    End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
    Catheter Cardiovasc Interv. 2021;98:246-254.
    PubMed         Abstract available
    
    
54. SHEIKH O, Nguyen T, Bansal S, Prasad A, et al
    Acute kidney injury in cardiogenic shock: A comprehensive review.
    Catheter Cardiovasc Interv. 2021;98:E91-E105.
    PubMed         Abstract available
    
    
55. JANG WJ, Chun WJ, Park IH, Choi KH, et al
    Impact of stent designs of second-generation drug-eluting stents on long-term outcomes in coronary bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;98:458-467.
    PubMed         Abstract available
    
    
56. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2021;98:617-625.
    PubMed         Abstract available
    
    
57. VELAZQUEZ MARTIN M, Montero Cabezas JM, Huertas S, Nuche J, et al
    Clinical relevance of adding intravascular ultrasound to coronary angiography for the diagnosis of extrinsic left main coronary artery compression by a pulmonary artery aneurysm in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29194.
    PubMed         Abstract available
    
    
58. VETROVEC GW, Lim MJ, Needham KA
    Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: An episode-of-care analysis.
    Catheter Cardiovasc Interv. 2021;98:703-710.
    PubMed         Abstract available
    
    
59. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:197-205.
    PubMed         Abstract available
    
    
60. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    PubMed         Abstract available
    
    
61. LEE JH, Kim U, Kim JS, Hong SJ, et al
    Clinical implication of neointimal burden in in-stent restenosis treated with drug-coated balloon.
    Catheter Cardiovasc Interv. 2021;98:493-502.
    PubMed         Abstract available
    
    
62. TAHIR H, Tonks R, Cox J, Baljepally R, et al
    Optimizing mechanical circulatory support hemodynamics using coronary sinus pacing.
    Catheter Cardiovasc Interv. 2021;98:E78-E84.
    PubMed         Abstract available
    
    
63. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2021;98:12-21.
    PubMed         Abstract available
    
    
64. BRIGUORI C, Golino M, Porchetta N, Scarpelli M, et al
    Impact of a contrast media volume control device on acute kidney injury rate in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;98:76-84.
    PubMed         Abstract available
    
    
65. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    PubMed         Abstract available
    
    
66. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2021;98:45-54.
    PubMed         Abstract available
    
    
67. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    PubMed         Abstract available
    
    
68. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    PubMed         Abstract available
    
    
69. TEHRANI DM, Seto AH
    Acute kidney injury in cardiogenic shock: The powerful distortions of survivor bias.
    Catheter Cardiovasc Interv. 2021;98:341-342.
    PubMed        
    
    
70. NAVARRO CASTELLANOS I, Dahdah N
    Letter to the Editor concerning the article: "Comparison of drug eluting versus bare metal stents".
    Catheter Cardiovasc Interv. 2021;98:E325.
    PubMed        
    
    
71. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:E324.
    PubMed        
    
    
72. BODE WD, Bode MF
    Chronic total occlusion revascularization for ventricular arrhythmias?-Still more work to be done.
    Catheter Cardiovasc Interv. 2021;98:409.
    PubMed        
    
    
73. SANZ SANCHEZ J, Garbo R, Gagnor A, Oreglia J, et al
    Management and outcomes of coronary artery perforations treated with the block and deliver technique.
    Catheter Cardiovasc Interv. 2021;98:238-245.
    PubMed         Abstract available
    
    
74. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    PubMed         Abstract available
    
    
75. VETROVEC GW
    Preventing NSTEMI readmissions: Starting from the beginning.
    Catheter Cardiovasc Interv. 2021;98:22-23.
    PubMed        
    
    
76. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    PubMed         Abstract available
    
    
77. KOH JS, Gogas BD, Kumar S, Benham JJ, et al
    Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;98:723-732.
    PubMed         Abstract available
    
    
78. BOEDER NF, Kastner J, Mehilli J, Munzel T, et al
    Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.
    Catheter Cardiovasc Interv. 2021;98:E555-E563.
    PubMed         Abstract available
    
    
79. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    PubMed         Abstract available
    
    
80. TROBS M, Achenbach S, Nef HM, Gori T, et al
    Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:E564-E570.
    PubMed         Abstract available
    
    
81. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    PubMed         Abstract available
    
    
82. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    PubMed         Abstract available
    
    
83. DAI Y, Ge J
    The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
    Catheter Cardiovasc Interv. 2021;98:43-44.
    PubMed        
    
    
84. MAATMAN B, Rios-Meza H, Guglin M, Revtyak G, et al
    A safe and simple method for axIABP placement using a left axillary-radial technique.
    Catheter Cardiovasc Interv. 2021;98:E310-E314.
    PubMed         Abstract available
    
    
85. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    PubMed        
    
    
86. VERHEYE S, Wlodarczak A, Montorsi P, Torzewski J, et al
    BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.
    Catheter Cardiovasc Interv. 2021;98:E1-E8.
    PubMed         Abstract available
    
    
87. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    PubMed         Abstract available
    
    
88. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    PubMed         Abstract available
    
    
89. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    PubMed         Abstract available
    
    
90. PIRIOU PG, Bonin M, Huchet F, Letocart V, et al
    Standardized fractal bench test evaluation of coronary stents: Performances in bifurcation lesions treated by the re-proximal optimization technique.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29288.
    PubMed         Abstract available
    
    
91. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    PubMed         Abstract available
    
    
92. HILLEGASS WB
    Diabetes and everolimus eluting bioresorbable poly-L-lactide vascular scaffolds for coronary artery disease: Dead-end or some path forward?
    Catheter Cardiovasc Interv. 2021;98:721-722.
    PubMed        
    
    
93. LANTZ R, Henry TD
    STEMI in 90-year-olds: The good news and the bad news!
    Catheter Cardiovasc Interv. 2021;98:647-648.
    PubMed        
    
    
94. ONO M, Kawashima H, Hara H, Gamal A, et al
    External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2021;98:E513-E522.
    PubMed         Abstract available
    
    

    
    Chest

95. MENDEZ R, Feced L, Alcaraz-Serrano V, Gonzalez-Jimenez P, et al
    Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
    Chest. 2021 Oct 14. pii: S0012-3692(21)04101-5. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

96. 
    Correction to: Culprit of Unstable Angina: A Large Left Ventricular Outflow Tract Pseudoaneurysm.
    Circ Cardiovasc Imaging. 2021 Oct 19:e000074. doi: 10.1161/HCI.0000000000000074.
    PubMed        
    
    

    
    Circ Cardiovasc Interv

97. JAIN P, Salama M, Everett K, Reyelt L, et al
    To Vent or Not to Vent: A Loaded Question During Venoarterial Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock.
    Circ Cardiovasc Interv. 2021;14:e010537.
    PubMed        
    
    
98. FERRONE M, Chieffo A, Khawaja SA, Moncada M, et al
    RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results.
    Circ Cardiovasc Interv. 2021;14:e010013.
    PubMed        
    
    
99. KANG DY, Ahn JM, Yun SC, Park H, et al
    Long-Term Clinical Impact of Intravascular Ultrasound Guidance in Stenting for Left Main Coronary Artery Disease.
    Circ Cardiovasc Interv. 2021;14:e011011.
    PubMed         Abstract available
    
    
100. ALASNAG M, Weisz G
     Intracoronary Imaging to Guide and Optimize: From Seeing Is Believing to Imaging Is Knowing.
     Circ Cardiovasc Interv. 2021;14:e011373.
     PubMed        
     
     

     
     Circ Genom Precis Med

101. XU H, Hon C, Kaiser S, Serrano-Fernandez P, et al
     Coronary Artery Disease Polygenic Risk Score Identifies Patients at Higher Risk for Recurrent Cardiovascular Events in the CANTOS Trial.
     Circ Genom Precis Med. 2021 Oct 19:CIRCGEN121003440.
     PubMed        
     
     

     
     Circulation

102. 
     Correction to: Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
     Circulation. 2021;144:e273.
     PubMed        
     
     
103. KHAN SU, Javed Z, Lone AN, Dani SS, et al
     Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
     Circulation. 2021;144:1272-1279.
     PubMed         Abstract available
     
     
104. GANGAVELLI A, Morris AA
     Premature Cardiovascular Mortality in the United States: Who Will Protect the Most Vulnerable Among Us?
     Circulation. 2021;144:1280-1283.
     PubMed        
     
     

     
     Clin Cardiol

105. MOHAMED A
     Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue.
     Clin Cardiol. 2021;44:1371-1376.
     PubMed         Abstract available
     
     
106. ECCLESTON DS, Kim JM, Ten Berg JM, Steg PG, et al
     The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic
     Clin Cardiol. 2021 May 27. doi: 10.1002/clc.23649.
     PubMed         Abstract available
     
     
107. DIAO K, Wang D, Chen Z, Wu X, et al
     Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
     Clin Cardiol. 2021 Oct 20. doi: 10.1002/clc.23744.
     PubMed         Abstract available
     
     
108. KIM YK, Jang CW, Kwon SH, Kim JH, et al
     Ten-year clinical outcomes in patients with intermediate coronary stenosis according to the combined culprit lesion.
     Clin Cardiol. 2021;44:1161-1168.
     PubMed         Abstract available
     
     
109. TANG J, Hou H, Chu J, Chen F, et al
     Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis.
     Clin Cardiol. 2021;44:978-986.
     PubMed         Abstract available
     
     
110. KONIGSTEIN M, Ponticelli F, Zivelonghi C, Merdler I, et al
     Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
     Clin Cardiol. 2021;44:424-428.
     PubMed         Abstract available
     
     
111. HUANG W, Lim LMH, Aurangzeb AS, Wong CJ, et al
     Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification.
     Clin Cardiol. 2021;44:267-275.
     PubMed         Abstract available
     
     
112. HOFER F, Kazem N, Schweitzer R, Horvat P, et al
     The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies.
     Clin Cardiol. 2021 Oct 19. doi: 10.1002/clc.23741.
     PubMed         Abstract available
     
     
113. GONG Y, Li X, Ma X, Yu H, et al
     Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II.
     Clin Cardiol. 2021 Oct 15. doi: 10.1002/clc.23725.
     PubMed         Abstract available
     
     

     
     Dtsch Med Wochenschr

114. VIETHEER JM, Hamm CW, Rolf A
     [Current role of cardiac magnetic resonance (CMR) in diagnosis and therapy of myocardial diseases].
     Dtsch Med Wochenschr. 2021;146:461-465.
     PubMed         Abstract available
     
     

     
     Eur Heart J

115. TSUDA K, Kanzaki Y, Hoshiga M
     Early cardiac magnetic resonance leads to diagnose the etiology of myocardial infarction with non-obstructive coronary arteries.
     Eur Heart J. 2021 Oct 18. pii: 6400298. doi: 10.1093.
     PubMed        
     
     
116. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
     Early invasive coronary angiography and acute ischaemic heart failure outcomes.
     Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
     PubMed         Abstract available
     
     
117. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
     Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
     Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
     PubMed         Abstract available
     
     

     
     Heart

118. RAQABANI MA, Musa AM, Al-Assaf OY
     ST elevation in a critically ill patient with COVID-19: what is the emergency treatment?
     Heart. 2021;107:1703-1764.
     PubMed        
     
     
119. ASLEH R
     Persistent sex differences in outcomes after coronary heart disease: time to move from observation to action.
     Heart. 2021 Oct 19. pii: heartjnl-2021-320031. doi: 10.1136/heartjnl-2021-320031
     PubMed        
     
     

     
     Int J Cardiol

120. LI KS, Bai Y, Li J, Li SL, et al
     LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway.
     Int J Cardiol. 2021;342:72-81.
     PubMed         Abstract available
     
     
121. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
     Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
     Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
     PubMed         Abstract available
     
     
122. COOK CM, Howard JP, Ahmad Y, Shun-Shin MJ, et al
     Comparing invasive hemodynamic responses in adenosine hyperemia versus physical exercise stress in chronic coronary syndromes.
     Int J Cardiol. 2021;342:7-14.
     PubMed         Abstract available
     
     
123. SHLOFMITZ E, Torguson R, Zhang C, Mintz GS, et al
     Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).
     Int J Cardiol. 2021;340:17-21.
     PubMed         Abstract available
     
     
124. TRAVERSE JH
     The coronary sinus reducer - Where modern technology meets old school physiology!
     Int J Cardiol. 2021;342:31-32.
     PubMed        
     
     
125. YONG ASC, Pargaonkar VS, Wong CCY, Javadzdegan A, et al
     Abnormal shear stress and residence time are associated with proximal coronary atheroma in the presence of myocardial bridging.
     Int J Cardiol. 2021;340:7-13.
     PubMed         Abstract available
     
     
126. ONO M, Kawashima H, Hara H, Mancone M, et al
     Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.
     Int J Cardiol. 2021;341:9-12.
     PubMed         Abstract available
     
     
127. WEBB CM, Collins P
     Medical management of anginal symptoms in women with stable angina pectoris: A systematic review of randomised controlled trials.
     Int J Cardiol. 2021;341:1-8.
     PubMed         Abstract available
     
     
128. GIOVANNINI M, Koniari I, Mori F, Barni S, et al
     Kounis syndrome: Towards a new classification.
     Int J Cardiol. 2021;341:13-14.
     PubMed        
     
     
129. ZORZI A, Brunetti G, Cardaioli F, D'Arcangelo F, et al
     Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.
     Int J Cardiol. 2021;339:219-224.
     PubMed         Abstract available
     
     
130. ANGELINI P, Uribe C
     Where's the beef in anomalous coronary artery origin from an opposite aortic sinus?
     Int J Cardiol. 2021;339:45-46.
     PubMed        
     
     
131. JANG WJ, Park IH, Yang JH, Chun WJ, et al
     Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry.
     Int J Cardiol. 2021;339:70-74.
     PubMed         Abstract available
     
     
132. LIU H, Bi K, Hu Y
     Targeting vimentin in coronary artery disease.
     Int J Cardiol. 2021;339:144.
     PubMed        
     
     
133. ISHIHARA T, Dohi T, Nakamura D, Kikuchi A, et al
     Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment.
     Int J Cardiol. 2021;339:28-32.
     PubMed         Abstract available
     
     
134. REINDL M, Lechner I, Reinstadler SJ, Metzler B, et al
     Transient STEMI - No STEMI at all?
     Int J Cardiol. 2021;339:12-13.
     PubMed        
     
     
135. GUO Y, Li Q, Xuan YT, Wu WJ, et al
     Exercise-induced late preconditioning in mice is triggered by eNOS-dependent generation of nitric oxide and activation of PKCepsilon and is mediated by increased iNOS activity.
     Int J Cardiol. 2021;340:68-78.
     PubMed         Abstract available
     
     
136. XU JJ, Cui J, Lin Q, Chen XY, et al
     Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury.
     Int J Cardiol. 2021;342:82-93.
     PubMed         Abstract available
     
     
137. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
     Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
     Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
     PubMed         Abstract available
     
     
138. TANG LH, Harrison A, Skou ST, Doherty P, et al
     To what extent are comorbidity profiles associated with referral and uptake to cardiac rehabilitation.
     Int J Cardiol. 2021;343:85-91.
     PubMed         Abstract available
     
     
139. DIXON LK, Di Tommaso E, Dimagli A, Sinha S, et al
     Impact of sex on outcomes after cardiac surgery: A systematic review and meta-analysis.
     Int J Cardiol. 2021;343:27-34.
     PubMed         Abstract available
     
     
140. PYXARAS SA, Harmel EK
     Artificial intelligence for the assessment of coronary artery disease- The dawn of a new era?
     Int J Cardiol. 2021;343:3-4.
     PubMed        
     
     
141. FENDER AC, Dobrev D
     Nitric oxide as a fragile switch between cardioprotection and cardiac injury.
     Int J Cardiol. 2021;343:102-103.
     PubMed        
     
     
142. NAKAJIMA A, Subban V, Russo M, Bryniarski KL, et al
     Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study.
     Int J Cardiol. 2021;343:171-179.
     PubMed         Abstract available
     
     
143. TSUGU T, Tanaka K, Belsack D, Devos H, et al
     Impact of vascular morphology and plaque characteristics on computed tomography derived fractional flow reserve in early stage coronary artery disease.
     Int J Cardiol. 2021;343:187-193.
     PubMed         Abstract available
     
     
144. ARCHILLETTI F, Zimarino M
     Intravascular ultrasound for in-stent restenosis: A problem well stated is half-solved.
     Int J Cardiol. 2021;340:22-23.
     PubMed        
     
     

     
     J Am Coll Cardiol

145. DZAYE O, Razavi AC, Dardari ZA, Shaw LJ, et al
     Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults.
     J Am Coll Cardiol. 2021;78:1573-1583.
     PubMed         Abstract available
     
     

     
     J Cardiovasc Pharmacol

146. HORIKOSHI T, Nakamura T, Yoshizaki T, Nakamura J, et al
     Stratification Analysis of Statin Effect on Major Adverse Cardiac Events after Percutaneous Coronary Intervention in Patients on Hemodialysis.
     J Cardiovasc Pharmacol. 2021 Oct 6. pii: 00005344-900000000-98138.
     PubMed         Abstract available
     
     
147. ASSMANN AK, Goschmer D, Sugimura Y, Chekhoeva A, et al
     A role for peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonists in counteracting the degeneration of cardiovascular grafts.
     J Cardiovasc Pharmacol. 2021 Oct 4. pii: 00005344-900000000-98134.
     PubMed         Abstract available
     
     

     
     J Mol Cell Cardiol

148. PALIOURA D, Lazou A, Drosatos K
     Kruppel-like factor (KLF)5: An emerging foe of cardiovascular health.
     J Mol Cell Cardiol. 2021 Oct 12. pii: S0022-2828(21)00193.
     PubMed         Abstract available
     
     

     
     J Thorac Cardiovasc Surg

149. GRAU JB
     Commentary: Statins for secondary prevention after coronary artery bypass grafting: Pleiotropic effects and dementia risk.
     J Thorac Cardiovasc Surg. 2021 Sep 20. pii: S0022-5223(21)01381.
     PubMed        
     
     
150. ANDERSON RH, Turner JE, Henderson DJ
     The morphogenesis of abnormal coronary arteries in the congenitally malformed heart.
     J Thorac Cardiovasc Surg. 2021 Oct 4. pii: S0022-5223(21)01406.
     PubMed        
     
     
151. WANG H, Hironaka CE, Mullis DM, Lucian HJ, et al
     A neonatal leporine model of age-dependent natural heart regeneration after myocardial infarction.
     J Thorac Cardiovasc Surg. 2021 Aug 17. pii: S0022-5223(21)01211.
     PubMed         Abstract available
     
     

     
     N Engl J Med

152. 
     Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
     N Engl J Med. 2021;385:1632.
     PubMed        
     
     

     
     PLoS One

153. RIFFEL JH, Siry D, Salatzki J, Andre F, et al
     Feasibility of fast cardiovascular magnetic resonance strain imaging in patients presenting with acute chest pain.
     PLoS One. 2021;16:e0251040.
     PubMed         Abstract available
     
     
154. JANG WM, Lee J, Eun SJ, Yim J, et al
     Travel time to emergency care not by geographic time, but by optimal time: A nationwide cross-sectional study for establishing optimal hospital access time to emergency medical care in South Korea.
     PLoS One. 2021;16:e0251116.
     PubMed         Abstract available
     
     
155. GARCHEVA V, Akin M, Adel J, Sanchez Martinez C, et al
     High rate of critical coronary stenosis in comatose patients with Non-ST-elevation out-of-hospital cardiac arrest (NSTE-OHCA) undergoing therapeutic hypothermia-Experience from the HAnnover COoling REgistry (HACORE).
     PLoS One. 2021;16:e0251178.
     PubMed         Abstract available
     
     
156. MURAOKA S, Somiya D, Ebata A, Kumagai Y, et al
     Future stroke risk in the chronic phase of post-percutaneous coronary intervention.
     PLoS One. 2021;16:e0251253.
     PubMed         Abstract available
     
     
157. CHOI BG, Hong JY, Rha SW, Choi CU, et al
     Long-term outcomes of peripheral arterial disease patients with significant coronary artery disease undergoing percutaneous coronary intervention.
     PLoS One. 2021;16:e0251542.
     PubMed         Abstract available
     
     
158. TOYA T, Ozcan I, Corban MT, Sara JD, et al
     Compositional change of gut microbiome and osteocalcin expressing endothelial progenitor cells in patients with coronary artery disease.
     PLoS One. 2021;16:e0249187.
     PubMed         Abstract available
     
     

     
     Psychosom Med

159. DOYLE F, Freedland KE, Carney RM, de Jonge P, et al
     Hybrid Systematic Review and Network Meta-Analysis of Randomized Controlled Trials of Interventions for Depressive Symptoms in Patients With Coronary Artery Disease.
     Psychosom Med. 2021;83:423-431.
     PubMed         Abstract available
     
     
160. MCKINNON II, Shah AJ, Lima B, Moazzami K, et al
     Everyday Discrimination and Mental Stress-Induced Myocardial Ischemia.
     Psychosom Med. 2021;83:432-439.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: